Drug intelligence / Profile preview

lactobacillus bulgaricus + streptococcus thermophilus + lactobacillus acidophilus + bifidobacterium lactis + lactobacillus casei LC2W

Development stage: Unknown
Lead developer: Bright Dairy
Modality: Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Administration: Oral

Overview

This probiotic combination is a multi-strain live biotherapeutic product primarily developed and marketed by Bright Dairy & Food. It consists of five specific bacterial strains: *Lactobacillus delbrueckii* subsp. *bulgaricus*, *Streptococcus thermophilus*, *Lactobacillus acidophilus*, *Bifidobacterium animalis* subsp. *lactis*, and the proprietary strain *Lactobacillus casei* LC2W. The formulation is designed to modulate the gut microbiota, enhance intestinal barrier function, and improve gastrointestinal motility. The *L. casei* LC2W strain, a key component of the mixture, has been characterized for its high acid and bile salt tolerance, as well as its ability to produce short-chain fatty acids (SCFAs) and exert anti-inflammatory effects. Clinical studies have investigated this combination for its efficacy in alleviating functional constipation and improving metabolic parameters in patients with metabolic syndrome.

Brand names: Changyou
Other names: Bright Dairy 5-strain probioticLactobacillus delbrueckii subsp. bulgaricus + Streptococcus thermophilus + Lactobacillus acidophilus + Bifidobacterium animalis subsp. lactis + Lactobacillus casei LC2W

Beyond the preview

Go deeper on lactobacillus bulgaricus + streptococcus thermophilus + lactobacillus acidophilus + bifidobacterium lactis + lactobacillus casei LC2W.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on lactobacillus bulgaricus + streptococcus thermophilus + lactobacillus acidophilus + bifidobacterium lactis + lactobacillus casei LC2W.

Explore the full profile